The GOLD Podcast: Weekly Pharma Insights

In this GOLD nugget, Helena looks back at thoughts shared by Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma from our special International Women’s Day episode. Aliya reflects on her time playing basketball in her youth and fighting for gender equality both on and off the court, some key role models in her life and the importance of listening to engage rather than to reply.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Aliya’s full episode: https://www.emg-gold.com/post/podcast-international-womens-day-special

Bayer in top spot for equality, diversity and inclusion: https://www.emg-gold.com/post/bayer-in-top-spot-for-equality-diversity-and-inclusion

Setting the stage for a more equitable future: https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

Diversity: from ideas to action: https://www.emg-gold.com/post/diversity-from-ideas-to-action

This GOLD Nugget episode sees Helena reflect on some of the insights offered by Laurence Woollard, haemophilia patient advocate and Founder and Director of On The Pulse Consultancy. In these clips, Laurence shares his personal experience of living with haemophilia and his journey into patient advocacy, the knowledge gap between the pharmaceutical industry and patients living with rare diseases and more.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Laurence’s full episode: https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus

The progress and pain points of patient centricity: https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity

The rare disease disparity: https://www.emg-gold.com/post/the-rare-disease-disparity

BioMarin supports haemophilia documentary initiative https://www.emg-gold.com/post/biomarin-supports-haemophilia-documentary-initiative

Roche renews haemophilia pledge https://www.emg-gold.com/post/roche-renews-haemophilia-pledge

For this week’s GOLD nugget, Helena highlights not one but two of GOLD’s previous guests from the world of Medical Affairs: Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson, and Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology, AstraZeneca. They explore the potential value that can come from collaborating with different industries and some tips for measuring the value of medical affairs – it’s not one to be missed!

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Luca’s full episode: https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls

Luisa’s full episode: https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

The Leap from Medicine to Medical Affairs: https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs

As Helena and Marc wrap up this season, they’re joined by Mike Watson, Chief Executive Officer of Mevox – a company committed to bringing vaccine technology into the 21^st century.

Mike discusses the importance of developing new measles, mumps and rubella (MMR) vaccines, Mevox’s success so far in achieving this ambition – reaching series B funding – and its future trajectory, how COVID-19 will impact the future of vaccine development, along with a whole host of other fascinating insights. As Helena’s favourite interview of Season 2, it’s not one to be missed!

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The return of the vaccines https://www.emg-gold.com/post/the-return-of-the-vaccines

Routine vaccinations: road to recovery https://www.emg-gold.com/post/routine-vaccinations-road-to-recovery

A heyday for mRNA https://www.emg-gold.com/post/a-heyday-for-mrna

Moderna set to bring mRNA innovation to UK https://www.emg-gold.com/post/moderna-set-to-bring-mrna-innovation-to-uk

GSK warns against vaccine complacency https://www.emg-gold.com/post/gsk-warns-against-routine-vaccine-complacency

This week, Claire Gillis, CEO, VMLY&R Health joins Helena and Marc on the airwaves to discuss the health and pharma highlights from the recent Cannes Lions International Festival, including the power of technology, how to spend smart on campaigns and her top moment from the festival this year.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Talking to Claire Gillis https://www.emg-gold.com/post/podcast-talking-to-claire-gillis

Innovative tech, pharma supply chains and more https://www.emg-gold.com/post/podcast-innovative-tech-pharma-supply-chains-and-more

Spoonful of technology https://www.emg-gold.com/post/spoonful-of-technology-5

Cardiovascular catalyst launched by Novartis https://www.emg-gold.com/post/cardiovascular-catalyst-launched-by-novartis

In an interview double bill, Helena and Marc are joined two fantastic guests from the worlds of pharma marketing and commercial affairs. Michele Manto, Chief Commercial Officer, Galapagos, shares his thoughts on the differences in leading a large pharma company and an agile biotech, amongst other exciting topics, while Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk, talks all things marketing with insights into developing campaigns.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

A big boom in biotech https://www.emg-gold.com/post/a-big-boom-in-biotech 

Time to turn to TikTok https://www.emg-gold.com/post/time-to-turn-to-tiktok 

Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide

The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change 

In this episode, GOLD is joined by recent catalyst interviewee Claus Zieler, President of Established Markets, Astellas, who discusses crisis management, the importance of leaders in shaping company culture, the innovation he is most excited about, and much more.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Claus Zieler on leadership https://www.emg-gold.com/post/claus-zieler-on-leadership

Reverse mentoring: a how-to guide https://www.emg-gold.com/post/reverse-mentoring-a-how-to-guide

Supporting patients in a war zone https://www.emg-gold.com/post/supporting-patients-in-a-war-zone

The hard sell of cell and gene therapies https://www.emg-gold.com/post/the-hard-sell-of-cell-and-gene-therapies

In this week’s episode, the GOLD team is joined by Luca Dezzani, Vice President, Oncology Medical Affairs, Johnson & Johnson. After first meeting Luca when he contributed to a GOLD article about the transition from medicine to medical affairs in 2021, we invited him to join us on the airwaves to delve further into his experience within the function, he discusses how the medical affairs function has evolved, the future of the MSL, his views on the metaverse and the power of cross-industry partnership.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• The leap from medicine to medical affairs https://www.emg-gold.com/post/the-leap-from-medicine-to-medical-affairs 

• The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse 

• Driving access to digital, gene therapies and rare disease education https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus 

• The progress and pain points of patient centricity https://www.emg-gold.com/post/the-progress-and-pain-points-of-patient-centricity 

In this Men’s Health Week special, the GOLD team is joined by Peter Baker, Director, Global Action on Men's Health and Chumi Khurana, Global Head, Prostate Cancer Disease Area Stronghold, Janssen Oncology. The two guests reveal what they think are the most pressing issues within men’s health today, highlight the importance of awareness campaigns, and comment on the role pharma can play in encouraging men to engage with their health.   

In this episode of the podcast, the GOLD team is joined by Eric Bouilloux, Chief Development Officer, Istesso. Helena and Eric discuss his impressive career within the pharmaceutical space, drill down into the potential of immunometabolism in diseases like multiple sclerosis, highlight some tips and tricks for progressing within a chosen career path and review his predictions from his first interview with GOLD in 2019. 

In this episode, the GOLD team is joined by Natalie Yeadon, Co-Founder and CEO, Impetus Digital, to delve deeper into our recent feature, ‘Getting into gamification’, Content and Editorial Assistant Jade Williams talks to Natalie about how pharma companies can best implement gamification into their practices and what internal and external benefits they can gain.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Getting into gamification https://www.emg-gold.com/post/getting-into-gamification

The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse

The difficulties of digital upskilling https://www.emg-gold.com/post/the-difficulties-of-digital-upskilling

In this episode, GOLD speaks to Lenias Hwenda, Founder and CEO, Medicines for Africa, and Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Following on from GOLD’s recent ‘Pharma in South Africa’ feature, Lenias explains what the implementation of South Africa’s new healthcare system will mean for global pharma, as well as exploring genomics and market access. Alexander discusses his interest in pricing and access of pharmaceuticals, shares how value-based reimbursement is evolving and offers his thoughts on the new EU Health Technology Assessment procedure. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Pharma in South Africa https://www.emg-gold.com/post/pharma-in-south-africa

Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine

Seeking solutions to low income, low access https://www.emg-gold.com/post/seeking-solutions-to-low-income-low-access

Operation vaccines: access all areas https://www.emg-gold.com/post/operation-vaccines-access-all-areas

In this special bonus episode, GOLD’s Editor Helena Beer reflects on the themes and her own key takeaways from this month’s NEXT Pharma Summit. What challenges are facing pharma, and what does the industry need to do to overcome these? Assistant Editor Isabel O’Brien also catches up with the event’s founder and chairman Dario Safaric to discuss his event highlights and thoughts on pharma’s future.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Digitalisation: moving past paperless https://www.emg-gold.com/post/digitalisation-moving-past-paperless
• A cautionary tale of innovation https://www.emg-gold.com/post/a-cautionary-tale
• A silver lining of patient centricity https://www.emg-gold.com/post/a-silver-lining-for-patient-centricity
• The difficulties of digital upskilling https://www.emg-gold.com/post/the-difficulties-of-digital-upskilling

In this episode, GOLD is joined by Emma Booth, Executive Director, Global Business Process and Insights Lead, R&D Strategy and Operations at Amgen. She discusses medical affairs communication and strategy, the power of data initiatives and the roadblocks that are preventing these from reaching their full potential, plus balancing leadership with nurturing one’s own aspirations.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Fresh clarity on RWE integration https://www.emg-gold.com/post/fresh-clarity-on-rwe-integration

Standing out in a crowd of content https://www.emg-gold.com/post/standing-out-in-a-crowd-of-content

Discussing a new dawn for data https://www.emg-gold.com/post/discussing-a-new-dawn-for-data

The RWD revolution https://www.emg-gold.com/post/the-rwd-revolution

In this episode, GOLD is joined by two of the pharmaceutical industry’s most unwavering mental health advocates: Wendy Bartie, Senior Vice President, US Oncology, Bristol Myers Squibb, and Courtney Billington, President, Janssen Neuroscience. They discern what resources pharma companies should be making available to their employees, what the industry’s role is in supporting patient mental health and how they manage their own mental wellbeing. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Pressure on UK government over mental health https://www.emg-gold.com/post/pressure-on-uk-government-over-mental-health

The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change

Making a difference in terminal diseases https://www.emg-gold.com/post/making-a-difference-in-terminal-diseases

Routine vaccinations: road to recovery https://www.emg-gold.com/post/routine-vaccinations-road-to-recovery

In this episode, Helena is joined by Klaus Legau, Senior Advisor, Social Sustainability at Leo Pharma. Klaus reveals the most important facets of a social sustainability strategy and where he believes the pharmaceutical industry is falling short in this respect, as well as offering expert advice to those starting out in policy campaigning.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The driving seat of organisational change https://www.emg-gold.com/post/the-driving-seat-of-organisational-change

Novartis enhances social mobility commitments https://www.emg-gold.com/post/novartis-enhances-social-mobility-commitments

A joint mission for social justice https://www.emg-gold.com/post/a-joint-mission-for-social-justice

Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future

In this episode, GOLD speaks with Luisa Luciani-Silverman, US Medical Head of Immuno-Oncology at AstraZeneca. She discusses all things medical affairs, delving into analytics, evidence generation, hiring candidates from non-traditional backgrounds and much more. Following on from GOLD's recent online poll, the team also hears from some special guests about their take on using TikTok as a pharma marketing tool.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Time to Turn to TikTok? https://www.emg-gold.com/post/time-to-turn-to-tiktok

Fresh clarity on RWE integration https://www.emg-gold.com/post/fresh-clarity-on-rwe-integration

The uphill recruitment battle https://www.emg-gold.com/post/the-uphill-recruitment-battle

The metrics of medical affairs https://www.emg-gold.com/post/the-metrics-of-medical-affairs

In this episode, GOLD is joined by Aaron Grandy, Associate Director, Alira Health, and Co-Founder, Precision Healthcare Consulting, who discusses the aim of his start-up, GoMed, on access and health outcomes in Africa. Plus, Laurence Woollard, Founder and Director, On The Pulse Consultancy, joins the team to explore the haemophilia landscape and share key messages for the pharma industry.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

New TV show brings "voice to voiceless" in Africa https://www.emg-gold.com/post/new-tv-show-brings-voice-to-voiceless-in-africa

The rare disease disparity https://www.emg-gold.com/post/the-rare-disease-disparity

Seeking solutions to low income, low access https://www.emg-gold.com/post/seeking-solutions-to-low-income-low-access  

Bridging the digital health divide https://www.emg-gold.com/post/bridging-the-digital-health-divide

This week, Marc and Helena are back together in the studio once more, and to mark the midpoint of season two, GOLD’s Assistant Editor, Isabel O’Brien, joins them to check in on our guests’ predictions for 2022. Hear from Julie Ross, Kay Wesley and Jennifer Cain Birkmose as the team pours over their predictions to see if clinical trials have been drastically decentralised, whether hybrid events are here to stay and if pharma’s pandemic push for collaboration has continued.  

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Remote trials: replicating reality https://www.emg-gold.com/post/remote-trials-replicating-reality 

Interview with Claire Skentelbery https://www.emg-gold.com/post/podcast-claire-skentelbery-director-general-europabio 

Interview with Judy Stewart https://www.emg-gold.com/post/we-ve-lost-the-focus-that-we-had-on-routine-vaccination-of-preventable-diseases